Development of an inactivated vaccine candidate for SARS-CoV-2

Gao, Qiang, Bao, Linlin, Mao, Haiyan, Wang, Lin, Xu, Kangwei, Yang, Minnan, Li, Yajing, Zhu, Ling +26 more·2020·Science

DOI 10.1126/science.abc1932

Cited by (1,438)

Items 701–800 of 1,438

Revolutionizing viral disease vaccination: the promising clinical advancements of non-replicating mRNA vaccines
Xiao Guo, Dongying Liu, Yukai Huang, Youcai Deng, Ying Wang, Jingrui Mao, Yuancheng Zhou, Yongai Xiong, Xinghong Gao · 2023 · Virology Journal
Exigency of Plant-Based Vaccine against COVID-19 Emergence as Pandemic Preparedness
Anirudha Chattopadhyay, A. Abdul Kader Jailani, Bikash Mandal · 2023 · Vaccines
Comparison of antigen-specific B cell responses reveals disparity in immunogenicity and memory B cell formation across COVID-19 vaccine platforms
Chang Ming Guo, Xin Chai, Maidaiti Baerlike, Yingping Liu, Yao Wang, Fei Shao, Qingrui Huang, Weiguo Zhang, Shan Cen, Yijie Dong et al. · 2024 · hLife
Frontrunners in the race to develop a SARS-CoV-2 vaccine
Raquel Russell, Peter Pelka, Brian L. Mark · 2020 · Canadian Journal of Microbiology
Cellular and Molecular Immunology Approaches for the Development of Immunotherapies against the New Coronavirus (SARS‐CoV‐2): Challenges to Near‐Future Breakthroughs
Juliana Gil Melgaço, Danielle Brito e Cunha, Tamiris Azamor, Andréa Marques Vieira da Silva, Luciana Neves Tubarão, Rafael Braga Gonçalves, Robson Q. Monteiro, Sotiris Missailidis, Patrícia Neves, Ana Paula Dinis Ano Bom · 2020 · Journal of Immunology Research
Immunogenicity of Adjuvanted Psoralen-Inactivated SARS-CoV-2 Vaccines and SARS-CoV-2 Spike Protein DNA Vaccines in BALB/c Mice
Appavu K. Sundaram, Daniel F. Ewing, Zhaodong Liang et al. · 2021 · Pathogens
Waning antibodies from inactivated SARS-CoV-2 vaccination offer protection against infection without antibody-enhanced immunopathology in rhesus macaque pneumonia models
Dandan Li, Ning Luan, Jing Li, Heng Zhao, Ying Zhang, Runxiang Long, Guorun Jiang, Shengtao Fan, Xingli Xu, Han Cao et al. · 2021 · Emerging Microbes & Infections
Potential metal‐related strategies for prevention and treatment of COVID‐19
Yaqiong Ni, Huihui Zeng, Xianwen Song, Jun Zheng, Hui‐Qiong Wu, Chuntai Liu, Yi Zhang · 2022 · Rare Metals
Fast and Accurate Surrogate Virus Neutralization Test Based on Antibody-Mediated Blocking of the Interaction of ACE2 and SARS-CoV-2 Spike Protein RBD
Denis Kolesov, Maria V. Sinegubova, Lutsia K. Dayanova, Inna V. Dolzhikova, Ivan Ivanovich Vorobiev, Nadezhda A. Orlova · 2022 · Diagnostics
Resilience and intention of healthcare workers in China to receive a COVID‐19 vaccination: The mediating role of life satisfaction and stigma
Phoenix K. H. Mo, Rui She, Yanqiu Yu, Lijuan Li, Qian Yang, Jianyan Lin, Xiaoli Ye, Suliu Wu, Zhenggui Yang, Suzhen Guan et al. · 2022 · Journal of Advanced Nursing
Intranasal Coronavirus SARS-CoV-2 Immunization with Lipid Adjuvants Provides Systemic and Mucosal Immune Response against SARS-CoV-2 S1 Spike and Nucleocapsid Protein
Anirban Sengupta, Mohammad Azharuddin, Maria E. Cardona, Claudia Devito, Eleanore von Castelmur, Anna Wehlin, Zuzanna Pietras, Maria Sunnerhagen, Robert Selegård, Daniel Aili et al. · 2022 · Vaccines
Safety and protective capability of an inactivated SARS-CoV-2 vaccine on pregnancy, lactation and the growth of offspring in hACE2 mice
Kaili Lin, Meixuan Liu, Linlin Bao, Qi Lv, Huachen Zhu, Dan Li, Yanfeng Xu, Zhiguang Xiang, Jiangning Liu, Xujian Liang et al. · 2022 · Vaccine
Novel coronavirus mutations: Vaccine development and challenges
Wan-Rong Luo, Xiaomin Wu, Wei Wang, Junling Yu, Qingqing Chen, Xue Zhou, Xiner Huang, Hai‐Feng Pan, Zhirong Liu, Yong Gao et al. · 2022 · Microbial Pathogenesis
Immunogenic profile of SARS-CoV-2 spike in individuals recovered from COVID-19
Jennifer A. Juno, Hyon‐Xhi Tan, Wen Shi Lee, Arnold Reynaldi, Hannah G. Kelly, Kathleen M. Wragg, Robyn Esterbauer, Helen E. Kent, C. Jane Batten, Francesca L. Mordant et al. · 2020 · medRxiv
“Acute Respiratory Distress and Cytokine Storm in Aged, SARS-CoV-2 Infected African Green Monkeys, but not in Rhesus Macaques”
Robert V. Blair, Monica Vaccari, Lara A. Doyle‐Meyers, Chad J. Roy, Kasi Russell‐Lodrigue, Marissa D. Fahlberg, Chris J. Monjure, Brandon J. Beddingfield, Kenneth S. Plante, Jessica A. Plante et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
Immunopathology, host-virus genome interactions, and effective vaccine development in SARS-CoV-2
D. Singh, Ihn Han, E. Choi, D. Yadav · 2020 · Computational and Structural Biotechnology Journal
Anxiety and fear related to coronavirus disease 2019 assessment in the Spanish population: A cross-sectional study
Regina Allande‐Cussó, Marta Linares Manrique, Juan Camilo Gómez-Salgado, Adolfo Romero Ruiz, Macarena Romero‐Martín, Juan Jesús García‐Iglesias, Carlos Ruíz-Frutos · 2021 · Science Progress
Alterations in 18F-FDG PET/MRI and 15O-Water PET Brain Findings in Patients With Neurological Symptoms After COVID-19 Vaccination
Dheeratama Siripongsatian, Anchisa Kunawudhi, Chetsadaporn Promteangtrong, Peerapon Kiatkittikul, Attapon Jantarato, Arthita Choolam, Krongkamol Ponglikitmongkol, Taweegrit Siripongboonsitti, Tharathorn Kaeowirun, Chanisa Chotipanich · 2022 · Clinical Nuclear Medicine
Comparison of Physical and Biochemical Characterizations of SARS-CoV-2 Inactivated by Different Treatments
Shouzhi Yu, Yangyang Wei, Hongyang Liang, Wenheng Ji, Zhen Chang, Siman Xie, Yichuan Wang, Wanli Li, Yingwei Liu, Hao Wu et al. · 2022 · Viruses
Differences in the immune response elicited by two immunization schedules with an inactivated SARS-CoV-2 vaccine in a randomized phase 3 clinical trial
Nicolás M. S. Gálvez, Gaspar A. Pacheco, Bárbara M. Schultz et al. · 2022 · eLife
Rapid evaluation of heterologous chimeric RBD-dimer mRNA vaccine for currently-epidemic Omicron sub-variants as booster shot after inactivated vaccine
Qian Chen, Pei Du, Yuxuan Han, Xuehui Ma, Rong Zhang, Xiaoyu Rong, Xu Zhao, Renyi Ma, Huiting Yang, Anqi Zheng et al. · 2023 · Biosafety and Health
SARS‐CoV‐2 surveillance for a non‐human primate breeding research facility
J. Yee, K. V. van Rompay, A. Carpenter, P. Nham, B. Halley, Smita S. Iyer, D. Hartigan-O'Connor, C. Miller, Jeffrey A. Roberts · 2020 · Journal of medical primatology
Revisiting the Immune Balance Theory: A Neurological Insight Into the Epidemic of COVID-19 and Its Alike
Junjiao Wu, Yu Tang · 2020 · Frontiers in Neurology
Recent updates on immunological, pharmacological, and alternative approaches to combat COVID-19
Ammara Saleem, Muhammad Furqan Akhtar, Muhammad Haris, Mohamed M. Abdel‐Daim · 2021 · Inflammopharmacology
Animal experiments show impact of vaccination on reduction of SARS-CoV-2 virus circulation: A model for vaccine development?
J. Vandeputte, Pierre Van Damme, Johan H. Neyts, Jean-Christophe Audonnet, Marc F.D. Baay, Pieter Neels · 2021 · Biologicals
A Self-Biomineralized Novel Adenovirus Vectored COVID-19 Vaccine for Boosting Immunization of Mice
Shengxue Luo, Panli Zhang, Peng Zou, Cong Wang, Bochao Liu, Cuiling Wu, Tingting Li, Ling Zhang, Yuming Zhang, Chengyao Li · 2021 · Virologica Sinica
Epigenetic glycosylation of SARS-CoV-2 impact viral infection through DC&L-SIGN receptors
Lei Guo, Yan Liang, Heng Li, Huiwen Zheng, Zening Yang, Yanli Chen, Xin Zhao, Jing Li, Binxiang Li, Haijing Shi et al. · 2021 · iScience
Blood Coagulation and Thrombotic Disorders following SARS-CoV-2 Infection and COVID-19 Vaccination
Metodija Sekulovski, Niya Boykova Mileva, Georgi Vasilev, Dimitrina Miteva, Milena Gulinac, Monika Peshevska-Sekulovska, Lyubomir Chervenkov, Hristiana Batselova, Georgi Vasilev, L Tomov et al. · 2023 · Biomedicines
First-Principles Simulation of Dielectric Function in Biomolecules
Puja Adhikari, Rudolf Podgornik, Bahaa Jawad · 2021 · Materials
Research Progress in the Treatment of Complications and Sequelae of COVID-19
Jinpeng Wang, Kuoyun Zhu, Yuchuan Xue, Guangfu Wen, Lin Tao · 2021 · Frontiers in Medicine
Comparing T- and B-cell responses to COVID-19 vaccines across varied immune backgrounds
Zhen Cui, Wenxin Luo, Ruihong Chen, Yalun Li, Zhoufeng Wang, Liu Y, Shuo Liu, Leilei Feng, Zijing Jia, Ruixin Cheng et al. · 2023 · Signal Transduction and Targeted Therapy
Efficacy and limitations of repurposed drugs and vaccines for COVID-19
Nensina Murmu, Mrinmoy Sarkar, Sananda Dey, Rahul Manna, Shreya Roy, Tanushree Mondal, Soma Halder, Nandini Bhattacharjee, Sandeep Kumar Dash, Biplab Giri · 2023 · Journal of Medicine Surgery and Public Health
Comparative Review of the State of the Art in Research on the Porcine Epidemic Diarrhea Virus and SARS-CoV-2, Scope of Knowledge between Coronaviruses
Nora Hilda Rosas-Murrieta, Alan Rodríguez-Enríquez, Irma Herrera Camacho, Lourdes Millán-Pérez-Peña, Gerardo Santos‐López, José Francisco Rivera-Benítez · 2024 · Viruses
Pathogenesis and virulence of coronavirus disease: Comparative pathology of animal models for COVID-19
Natalie M. Kirk, Yu-Ying Liang, H. Ly · 2024 · Virulence
An Assessment of Healthcare Workers Knowledge about COVID-19
Hadi Jaber Al Sulayyim, Mohammed Chyad Al-Noaemi, Saleh Mohsen Rajab · 2020 · Open Journal of Epidemiology
Human Monoclonal Antibodies: On the Menu of Targeted Therapeutics Against COVID-19
Junsen Chen, Rui Huang, Yiwen Nie, Xinyue Wen, Ying Wu · 2020 · Virologica Sinica
Immunity, virus evolution, and effectiveness of SARS-CoV-2 vaccines
José Ernesto Belizário · 2021 · Brazilian Journal of Medical and Biological Research
SARS-CoV-2 vaccine development and how Brazil is contributing
Alex Issamu Kanno, Mayra Mara Ferrari Barbosa, Luana Moraes, Luciana C. C. Leite · 2021 · Genetics and Molecular Biology
A Modular Biomaterial Scaffold‐Based Vaccine Elicits Durable Adaptive Immunity to Subunit SARS‐CoV‐2 Antigens
Fernanda Langellotto, Maxence O. Dellacherie, Chyenne D. Yeager, Hamza Ijaz, Jingyou Yu, Chi‐An Cheng, Nikolaos Dimitrakakis, Benjamin T. Seiler, Makda S. Gebre, Tal Gilboa et al. · 2021 · Advanced Healthcare Materials
A single intranasal dose of human parainfluenza virus type 3-vectored vaccine induces effective antibody and memory T cell response in the lungs and protects hamsters against SARS-CoV-2
Philipp A. Ilinykh, Sivakumar Periasamy, Kai Huang, Natalia A. Kuzmina, Palaniappan Ramanathan, Michelle N. Meyer, Chad E. Mire, Ivan V. Kuzmin, Preeti Bharaj, Jessica R. Endsley et al. · 2022 · npj Vaccines
Essential considerations during vaccine design against COVID-19 and review of pioneering vaccine candidate platforms
Maryam Bayat, Yahya Asemani, Sajad Najafi · 2021 · International Immunopharmacology
The first Chinese national standards for SARS-CoV-2 neutralizing antibody
Lidong Guan, Yuanling Yu, Xiaohong Wu, Jianhui Nie, Jun Zhang, Zejun Wang, Na Li, Rui Shi, Hui John Zhao, Hongbo Chen et al. · 2021 · Vaccine
Vaccine Candidate Against COVID-19 Based on Structurally Modified Plant Virus as an Adjuvant
Angelina O. Kovalenko, Ekaterina M. Ryabchevskaya, Ekaterina A. Evtushenko, Tatiana I. Manukhova, Olga A. Kondakova, Ivanov Pa, Marina V. Arkhipenko, Vladimir А. Gushchin, Nikolai A. Nikitin, Olga V. Karpova · 2022 · Frontiers in Microbiology
SARS‐CoV‐2 replicating in nonprimate mammalian cells probably have critical advantages for COVID‐19 vaccines due to anti‐Gal antibodies: A minireview and proposals
Chen, Ji‐Ming · 2021 · Journal of Medical Virology
Immunology and Technology of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccines
Simone Pecetta, Sven Kratochvil, Yu Kato, Kumaran Vadivelu, Rino Rappuoli · 2022 · Pharmacological Reviews
A novel plant lectin, NTL-125, interferes with SARS-CoV-2 interaction with hACE2
Anindya Sarkar, Sathi Paul, Charandeep Singh, Nilkanta Chowdhury, Papri Nag, Swarnava Das, Sahil Kumar, Anshul Sharma, Deepjyoti Kumar Das, Dipak Dutta et al. · 2022 · Virus Research
Sophorolipid-toluidine blue conjugates for improved antibacterial photodynamic therapy through high accumulation
Xiaoxiao Gu, Lixian Xu, Haoyang Yuan · 2023 · RSC Advances
Immunological strategies against spike protein: Neutralizing antibodies and vaccine development for COVID‐19
Jiansheng Huang, Hui Huang, Dongdong Wang · 2020 · Clinical and Translational Medicine
An overview of some potential immunotherapeutic options against COVID-19
Maryam Bayat, Yahya Asemani, Mohammad Reza Mohammadi, Mahsa Sanaei, Mozhdeh Namvarpour, Reyhaneh Eftekhari · 2021 · International Immunopharmacology
COVID-19: Structural Considerations for Virus Pathogenesis, Therapeutic Strategies and Vaccine Design in the Novel SARS-CoV-2 Variants Era
Ender Volkan · 2021 · Molecular Biotechnology
Site-Specific and Stable Conjugation of the SARS-CoV-2 Receptor-Binding Domain to Liposomes in the Absence of Any Other Adjuvants Elicits Potent Neutralizing Antibodies in BALB/c Mice
Wei-Yun Wholey, Sekou-Tidiane Yoda, Wei Cheng · 2021 · Bioconjugate Chemistry
Seguridad de las vacunas contra la COVID-19
Nataniel- Aldo Chaparro-Mérida, Dayany Moreno Samper, Alex Omar Franco Lacato · 2021 · Revista Peruana de Medicina Experimental y Salud Pública
Attacking the Intruder at the Gate: Prospects of Mucosal Anti SARS-CoV-2 Vaccines
Kacper Karczmarzyk, Małgorzata Kęsik-Brodacka · 2022 · Pathogens
Peripheral Ulcerative Keratitis Secondary to the Inactive COVID-19 Vaccine-CoronaVac
Ayşegül Penbe · 2022 · Ocular Immunology and Inflammation
A review on COVID-19 transmission, epidemiological features, prevention and vaccination
Yuqin Zhang, Gonghua Wu, Shirui Chen, Jun Xu, Wumitijiang Yimaer, Wangjian Zhang, Shao Chia Chiu Lin, Yuantao Hao, Jing Gu, Jinghua Li · 2022 · Medical Review
Toxicity and Local Tolerance of a Novel Spike Protein RBD Vaccine Against SARS-CoV-2, Produced Using the C1 Thermothelomyces Heterothallica Protein Expression Platform
Yuval Ramot, Noam Kronfeld, Yakir Ophir et al. · 2022 · Toxicologic Pathology
Assessment of neutralizing antibody responses after natural SARS-CoV-2 infection and vaccination in congolese individuals
Armel Landry Batchi-Bouyou, Jean Claude Djontu, Jeannhey Christevy Vouvoungui, Claujens Chastel Mfoutou Mapanguy, Line Lobaloba Ingoba, Jiré Séphora Mougany, Reauchelvy Kamal Boumpoutou, Steve Diafouka-Kietela, Raoul Ampa, Francine Ntoumi · 2022 · BMC Infectious Diseases
Safety and immunogenicity of the first Kazakh inactivated vaccine for COVID-19
Ainur S. Nurpeisova, Berik M. Khairullin, Ruslan Abitayev et al. · 2022 · Human Vaccines & Immunotherapeutics
Targeted therapy in Coronavirus disease 2019 (COVID-19): Implication from cell and gene therapy to immunotherapy and vaccine
Moein Shirzad, Marjan Nourigorji, Atefe Sajedi, Maryam Ranjbar, Faeze Rasti, Zahra Sourani, Mona Moradi, Seyed Mostafa Mir, Mohammad Yousef Memar · 2022 · International Immunopharmacology
Potential for elimination of SAR‐CoV‐2 through vaccination as inspired by elimination of multiple influenza viruses through natural pandemics or mass vaccination
Jiming Chen, Ying‐Xue Sun, Jiwang Chen · 2020 · Journal of Medical Virology
Review: Development of SARS-CoV-2 immuno-enhanced COVID-19 vaccines with nano-platform
Nawamin Sa-nguanmoo, Katawut Namdee, Mattaka Khongkow, Uracha Ruktanonchai, Yongxiang Zhao, Xing‐Jie Liang · 2021 · Nano Research
COVID-19 Vaccination and Alcohol Consumption: Justification of Risks
Pavel A. Solopov · 2023 · Pathogens
Vaccines for Respiratory Viruses—COVID and Beyond
Kalpana Rajanala, Arun Upadhyay · 2024 · Vaccines
Inactivated vaccine for SARS-CoV-2
Emma Risson · 2020 · Nature reviews. Immunology
Induction of Potent and Durable Neutralizing Antibodies Against SARS-CoV-2 Using a Receptor Binding Domain-Based Immunogen
Vikram Srivastava, Ling Niu, Kruttika S. Phadke, Bryan H. Bellaire, Michael W. Cho · 2021 · Frontiers in Immunology
Deep Learning-Based Drug Screening for COVID-19 and Case Studies
Konda Mani Saravanan, Haiping Zhang, Md. Tofazzal Hossain, Md. Selim Reza, Yanjie Wei · 2021 · Methods in pharmacology and toxicology
Simultaneous quantification of spike and nucleocapsid protein in inactivated COVID-19 vaccine bulk by liquid chromatography-tandem mass spectrometry
Zhen Long, Wei Chen, Xuefang Dong, Xiuling Li, Hao Chun Yang, Haiqing Deng, Xiao Ma, Shanshan Yin, Yingzi Qi, Tao Bo · 2021 · Journal of Chromatography B
Protective Immunity against Gamma and Zeta Variants after Inactivated SARS-CoV-2 Virus Immunization
Marcílio Jorge Fumagalli, Luíza Antunes de Castro-Jorge, Thais Fernanda de Campos Fraga‐Silva, Patrick Orestes de Azevedo, Carlos Fabiano Capato, Bruna Amanda da Cruz Rattis, Natália Satchiko Hojo-Souza, Vitor Gonçalves Floriano, Júlia Teixeira de Castro, Simone Gusmão Ramos et al. · 2021 · Viruses
Influence of SARS-CoV-2 inactivation by different chemical reagents on the humoral response evaluated in a murine model
Emerson de Castro Barbosa, Adriana de Souza Andrade, Myrian Morato Duarte · 2022 · Molecular Immunology
Advances in nanotechnology application in biosafety materials: A crucial response to COVID-19 pandemic
Rasmi V. Morajkar, Akhil Sree Kumar, Rohan Keshav Kunkalekar, Amit Ashok Vernekar · 2022 · Biosafety and Health
Safety and Non-Inferiority Evaluation of Two Immunization Schedules with an Inactivated SARS-CoV-2 Vaccine in Adults: A Randomized Clinical Trial
Katia Abarca V, Carolina Iturriaga, Marcela D. Urzua, Nicole Le Corre, Augusto Pineda, Carolina Fernández, Angélica Domínguez, Pablo A. González, Susan M. Bueno, Paulina Donato et al. · 2022 · Vaccines
Investigating Impacts of CoronaVac Vaccination in Males on In Vitro Fertilization: A Propensity Score Matched Cohort Study
Meng Wang, Qiyu Yang, Lixia Zhu · 2022 · The World Journal of Men s Health
Folic acid restricts SARS-CoV-2 invasion by methylating ACE2
Yuanzhou Zhang, Yechun Pang, Baiyin Xu · 2022 · Frontiers in Microbiology
COVID-19: Vaccines and therapeutics
P. Swapna, Naga Venkata Suryanarayana Birudukota, Ahmed Kamal · 2022 · Bioorganic & Medicinal Chemistry Letters
An inactivated recombinant rabies virus chimerically expressed RBD induces humoral and cellular immunity against SARS-CoV-2 and RABV
Haili Zhang, Hongli Jin, Feihu Yan, Yumeng Song, Jiaxin Dai, Cuicui Jiao, Yujie Bai, Jingxuan Sun, Di Liu, Shen Wang et al. · 2022 · Virologica Sinica
Recent Advances in Photothermal Therapies Against Cancer and the Role of Membrane Transporter Modulators on the Efficacy of This Approach
Ahmed A. Abdulhussein Al-Ali, Nameer M AlWard, Mohammad A. Obeid · 2023 · Technology in Cancer Research & Treatment
An Advax-CpG55.2™ adjuvanted recombinant spike protein vaccine protects cynomolgus macaques from a homologous SARS-CoV-2 virus challenge
Yoshikazu Honda-Okubo, Lei Li, Greiciely Andre, King Ho Leong, E. Howerth, Anne-Gaelle Bebin-Blackwell, T. Ross, N. Petrovsky · 2023 · Vaccine
Newly Emerging Human Coronaviruses: Animal Models and Vaccine Research for SARS, MERS, and COVID-19
Pureum Lee, Doo-Jin Kim · 2020 · Immune Network
Recent advances in materials science: a reinforced approach toward challenges against COVID-19
Abhinav Saxena, Deepak Khare, Swati Agrawal, Angaraj Singh, Ashutosh Kumar Dubey · 2021 · Emergent Materials
A colloidal gold-based immunochromatographic strip for rapid detection of SARS-CoV-2 antibodies after vaccination
Jia Liu, Weiqi Yan, Zhuojun Liu · 2021 · Medicine in Novel Technology and Devices
Efficacy of antibody response following the vaccination of SARS‐CoV‐2 infected and noninfected healthcare workers by two‐dose inactive vaccine against COVID‐19
Bağnu Dündar, Kadriye Karahangil, Cagri Serdar ELGORMUS, Hatıce Nur Halıpcı Topsakal · 2022 · Journal of Medical Virology
A Newly Identified Spike Protein Targeted Linear B‐Cell Epitope Based Dissolvable Microneedle Array Successfully Eliciting Neutralizing Activities against SARS‐CoV‐2 Wild‐Type Strain in Mice
Lin Li, Zhongpeng Zhao, Xiaolan Yang, Zhongyi Su, Wendong Li, Shaolong Chen, Lu Wang, Ting Sun, Chen Du, Ziyi Li et al. · 2023 · Advanced Science
Origin, Causative and New Approach of Vaccine Design of COVID-19
Mothana Ali Khalil · 2020 · Al- Anbar Medical Journal
Next‐Generation Vaccines: Nanovaccines in the Fight against SARS‐CoV‐2 Virus and beyond SARS‐CoV‐2
Maluta Steven Mufamadi, Mpho Phehello Ngoepe, Ofentse Nobela, Nhlanhla Maluleke, Bafedile Phorah, Banele Methula, Thapelo Maseko, Dipuo Ingrid Masebe, Hazel Tumelo Mufhandu, Lebogang Katata‐Seru · 2023 · BioMed Research International
Analysis of the protective efficacy of approved COVID-19 vaccines against Omicron variants and the prospects for universal vaccines
Keda Chen, Ling Zhang, Zhongbiao Fang, Jiaxuan Li, Chaonan Li, Wancheng Song, Zhi‐wei Huang, Ruyi Chen, Yanjun Zhang, Jianhua Li · 2023 · Frontiers in Immunology
Understanding the determinants of vaccine hesitancy in the United States: A comparison of social surveys and social media
Kuleen Sasse, Ron Mahabir, Olga Gkountouna, Andrew T. Crooks, Arie Croitoru · 2024 · PLoS ONE
New insights on possible vaccine development against SARS-CoV-2
Sundas Nasir Chaudhry, Abu Hazafa, Muhummad Mumtaz, Ume Kalsoom, Saima Abbas, Amna Kainaat, Shahid Bilal, Nauman Zafar, Aleena Siddique, Ayesha Zafar · 2020 · Life Sciences
COVID-19 antibody development fueled by HIV-1 bNAb research
Pilar Mendoza, Julio C. C. Lorenzi, C. Gaebler · 2020 · Current Opinion in HIV and AIDS
SARS-CoV-2: Pathogenic Mechanisms and Host Immune Response.
Hadida Yasmin, Sudipta Saha, M. Butt, R. Modi, A. J. George, U. Kishore · 2021 · Advances in Experimental Medicine and Biology
Animal models for studying coronavirus infections and developing antiviral agents and vaccines
Qisheng Lin, Chunni Lu, Yuqi Hong, Runfeng Li, Jinding Chen, Weisan Chen, Jianxin Chen · 2022 · Antiviral Research
Nonhuman primate models for evaluation of SARS-CoV-2 vaccines
Jessica Anne Neil, Maryanne Griffith, Dale Ian Godfrey, Damian F. J. Purcell, Georgia Deliyannis, David Charles Jackson, Steve Rockman, Kanta Subbarao, Terry M. Nolan · 2022 · Expert Review of Vaccines
Recent advances in the vaccine development for the prophylaxis of SARS Covid-19
Vipul Kumar, Sahil Kumar, Prabodh Chander Sharma · 2022 · International Immunopharmacology
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
Sally A. Helmy, Rasha M. EL Morsi, Soha M. El-Masry, Soha M. El-Masry · 2022 · Journal of Drug Delivery Science and Technology
The Immune Efficacy of Inactivated Pseudorabies Vaccine Prepared from FJ-2012ΔgE/gI Strain
Qiuyong Chen, Xuemin Wu, Yongliang Che · 2022 · Microorganisms
An inactivated SARS-CoV-2 vaccine induced cross-neutralizing persisting antibodies and protected against challenge in small animals
Anna Offersgaard, Carlos Rene Duarte Hernandez, Shan Feng, Pavel Marichal‐Gallardo, Kenn Holmbeck, Anne Finne Pihl, Carlota Fernandez-Antunez, Garazi Peña Alzua, Katrine Top Hartmann, Long V. Pham et al. · 2023 · iScience
Effectiveness of Booster Vaccinations on the Control of COVID-19 during the Spread of Omicron Variant in Malaysia
Matthew Tze Jian Wong, Satvinder Singh Dhaliwal, Venugopal Balakrishnan, Fazlina Nordin, Mohd Nor Norazmi, Gee Jun Tye · 2023 · International Journal of Environmental Research and Public Health
Metabolomics acts as a powerful tool for comprehensively evaluating vaccines approved under emergency: a CoronaVac retrospective study
Xinyu Liu, Congshu Xiao, Pengwei Guan, Qianqian Chen, Lei You, Hongwei Kong, Wangshu Qin, Peng Dou, Qi Li, Yanju Li et al. · 2023 · Frontiers in Immunology
Evolution of global scientific collaboration in mRNA vaccine research: Insights from bibliometric and social network analysis (2010~2023)
Juan Chen, Lizi Pan, Yan Zhen Lu, Ting Zhang, Dongzi Xu, Shu Yan, Zhaolian Ouyang · 2023 · Human Vaccines & Immunotherapeutics
COVID-19 and Mesenchymal Stem Cell Treatment; Mystery or Not
Tunç Akkoç · 2020 · Advances in experimental medicine and biology
Antigenic properties of sARs-CoV-2/human/RUs/nsk-FRCFtM-1/2020 coronavirus isolate from a patient in novosibirsk
А. А. Чепурнов, Kirill Sharshov, E. I. Kazachinskaya · 2020 · Journal Infectology